SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-755505
Filing Date
2016-11-01
Accepted
2016-11-01 17:22:00
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d258325d10q.htm 10-Q 514901
2 EX-31.1 d258325dex311.htm EX-31.1 9924
3 EX-31.2 d258325dex312.htm EX-31.2 9889
4 EX-32.1 d258325dex321.htm EX-32.1 4115
5 EX-32.2 d258325dex322.htm EX-32.2 4064
  Complete submission text file 0001193125-16-755505.txt   3191364

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qlti-20160930.xml EX-101.INS 554784
7 XBRL TAXONOMY EXTENSION SCHEMA qlti-20160930.xsd EX-101.SCH 45625
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qlti-20160930_cal.xml EX-101.CAL 45762
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qlti-20160930_def.xml EX-101.DEF 136195
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qlti-20160930_lab.xml EX-101.LAB 335629
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qlti-20160930_pre.xml EX-101.PRE 230783
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 161965664
SIC: 2834 Pharmaceutical Preparations